11/10
08:03 am
gbio
Generation Bio (NASDAQ:GBIO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.
Medium
Report
Generation Bio (NASDAQ:GBIO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $15.00 price target on the stock.